Pacira Pharmaceuticals Inc. (PCRX) Climbed 5.17% or 2.48 To Price $50.33 On Wednesday


Pacira Pharmaceuticals Inc. (PCRX) climbed 5.17% or 2.48 to $50.33. It is about 732608 shares traded, which is 132.4% compare to the average total volume 553346. The market cap of PCRX is $2.06 billion. The year to date change is 8.52%. The 52 week price range is from $26.95 to $51.55. Price of PCRX have changed 3.01% during last week. It have changed 3.24% over last month, 28.63% over last 3 months, 55.99% over last 6 months and 31.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PCRX is 43.11. It is -14.35% below current price. The 200-day Moving Averages for PCRX is 38.02. It is -24.46% below current price. The 52-week High is 51.55. It is 2.42% from the current price. The 52-week Low is 26.95. It is -46.45% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PCRX is 4.11 on 2018-08-31. Short % to float is 6.48%. There are some statistics of PCRX. It is has market cap $2.06 billion. The share outstanding is 40.96 million. The average volume is 553346. The revenue is 67.34M. It has 294.08M cash and 273.04M in debt. The gross profit is 49.11M. The percent of top 15 Institution holding is 99.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PCRX is -4.03%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PCRX is -1.78%.


Tags:

Share this post